1 – 38 of 38
- show: 100
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Cost of Illness of Head and Neck Cancer in Sweden
2024) In Value in Health(
- Contribution to journal › Article
- 2023
-
Mark
Economic Evaluation of Elective Cesarean Section on Maternal Request Compared With Planned Vaginal Birth—Application to Swedish Setting Using National Registry Data
(
- Contribution to journal › Article
- 2022
-
Mark
The Value of Nonpharmacological Interventions for People With an Acquired Brain Injury: : A Systematic Review of Economic Evaluations
(
- Contribution to journal › Scientific review
-
Mark
The Use of Cost-Effectiveness Thresholds for Evaluating Health Interventions in Low- and Middle-Income Countries From 2015 to 2020 : A Review
(
- Contribution to journal › Article
- 2016
-
Mark
Patient Heterogeneity in Health Economic Decision Models for Chronic Obstructive Pulmonary Disease : Are Current Models Suitable to Evaluate Personalized Medicine?
(
- Contribution to journal › Article
- 2015
-
Mark
Applying Weighted Cumulative Exposure Models to Patterns of Nonspecific Symptom Consultations for Early Diagnosis: A Primary Care Database Study of Knee Pain and Osteoarthritis.
(
- Contribution to journal › Article
-
Mark
The Prostate Cancer Registry: Analysis of Medical Resource Utilisation (Mru) in An International, Prospective, Observational Study of Men with Metastatic Castration-Resistant Prostate Cancer (Mcrpc).
(
- Contribution to journal › Article
-
Mark
The Cost of Treating Recurrent Clostridium Difficile Infection In Patients Attending Infectious Disease Clinics At Four Hospitals In Sweden.
(
- Contribution to journal › Article
-
Mark
Hexaminolevulinate Blue-Light Flexible Cystoscopy In Addition To Standard White-Light Cystoscopy In The Follow-Up Of Non-Muscle Invasive Bladder Cancer: Cost-Consequences During Outpatient Surveillance In Sweden
(
- Contribution to journal › Article
- 2014
-
Mark
Treating to target with etanercept in rheumatoid arthritis: cost-effectiveness of dose reductions when remission is achieved.
(
- Contribution to journal › Article
-
Mark
Core discrete event simulation model for the evaluation of health care technologies in major depressive disorder.
(
- Contribution to journal › Article
-
Mark
Cost-Effectiveness Models for Chronic Obstructive Pulmonary Disease: Cross-Model Comparison of Hypothetical Treatment Scenarios
(
- Contribution to journal › Article
- 2013
-
Mark
The Comparison of Trial Data-Based and Registry Data-Based Cost-Effectiveness of Infliximab Treatment for Rheumatoid Arthritis in Sweden Using a Modeling Approach
(
- Contribution to journal › Article
- 2011
-
Mark
Internet-Based Follow-Up Questionnaire for Measuring Patient-Reported Outcome after Total Hip Replacement Surgery-Reliability and Response Rate
(
- Contribution to journal › Article
-
Mark
Pharmaceutical priority setting and the use of health economic evaluations: a systematic literature review.
(
- Contribution to journal › Article
- 2010
-
Mark
International Development of the Unidimensional Fatigue Impact Scale (U-FIS)
(
- Contribution to journal › Article
-
Mark
QUALITY OF LIFE AFTER CHEMOTHERAPY IN BREAST CANCER: A STUDY IN SOUTH OF IRAN
(
- Contribution to journal › Published meeting abstract
-
Mark
Cost-Effectiveness Analysis Of Cancer Treatments In South Of Iran
(
- Contribution to journal › Published meeting abstract
-
Mark
International Development of the Patient-Reported Outcome Indices for Multiple Sclerosis (PRIMUS)
(
- Contribution to journal › Article
-
Mark
Effects of Method of Translation of Patient-Reported Health Outcome Questionnaires: A Randomized Study of the Translation of the Rheumatoid Arthritis Quality of Life (RAQoL) Instrument for Sweden.
(
- Contribution to journal › Article
- 2009
-
Mark
RIMONABANT IN CLINICAL PRACTICE (RICP). A SWEDISH MULTICENTER SURVEY IN PRIMARY CARE
(
- Contribution to journal › Published meeting abstract
-
Mark
EVALUATION OF ALTERNATIVE METHODS OF TRANSLATING PATIENT-REPORTED OUTCOME MEASURES
(
- Contribution to journal › Published meeting abstract
-
Mark
A PATIENT SURVEY/CHART REVIEW STUDY ABOUT TREATMENT PATTERNS, COSTS AND QUALITY OF LIFE IN PATIENTS WITH PSORIASIS IN SWEDEN
(
- Contribution to journal › Published meeting abstract
-
Mark
A Cost Effectiveness Analysis Of A General Vaccination Programme With The New 10-Valent Pneumococcal Non-Typeable Haemophilus Influenzae Protein-D Conjugate Vaccine (Phid-Cv) In Sweden
(
- Contribution to journal › Published meeting abstract
-
Mark
Whose Quality of Life? Ethical Implications in Patient-Reported Health Outcome Measurement
(
- Contribution to journal › Article
-
Mark
Validation of Gastrointestinal Quality of Life Index in Swedish for Assessing the Impact of Gallstones on Health-Related Quality of Life
(
- Contribution to journal › Article
- 2008
-
Mark
Smoking-cessation therapy using varenicline - The cost-utility of an additional 12-week course of varenicline for the maintenance of smoking abstinence
(
- Contribution to journal › Published meeting abstract
-
Mark
TOPICAL TACROLIMUS FOR THE TREATMENT OF ATOPIC DERMATITIS: A SYSTEMATIC REVIEW WITH META-ANALYSES
(
- Contribution to journal › Published meeting abstract
-
Mark
Self-reported adverse events after groin hernia repair, a study based on a national register
(
- Contribution to journal › Article
-
Mark
THE COST-EFFECTIVENESS OF GROWTH HORMONE REPLACEMENT THERAPY WITH GENOTROPIN (R) IN HYPOPITUITARY ADULT PATIENTS
(
- Contribution to journal › Published meeting abstract
-
Mark
The burden of ankylosing spondylitis in Spain.
(
- Contribution to journal › Article
-
Mark
Cost-effectiveness of ritodrine and fenoterol for treatment of preterm labor in a low-middle-income country : a case study
(
- Contribution to journal › Article
- 2006
-
Mark
Cost of Ilness for adults with partial epilepsy in Sweden. ISPOR (International Society for Pharmacoeconomics and Outcomes Research)
(
- Contribution to journal › Published meeting abstract
- 2005
-
Mark
Obesity, survival, and hospital costs-findings from a screening project in sweden.
(
- Contribution to journal › Article
- 2004
-
Mark
Application of Rasch analysis in the development and application of quality of life instruments
(
- Contribution to journal › Article
-
Mark
Adapting quality of life instruments
(
- Contribution to journal › Article
-
Mark
A computer simulation model of the natural history and economic impact of chronic obstructive pulmonary disease
(
- Contribution to journal › Article
- 2000
-
Mark
The Cost-effectiveness of Treating Diabetic Lower Extremity Ulcers with Becaplermin (Regranex): A Core Model with an Application Using Swedish Cost Data.
(
- Contribution to journal › Article